FDA 483 - Chicago Indoor Garden, Inc. - June 28, 2021

An FDA inspection of Chicago Indoor Garden, Inc. revealed critical sanitation and record-keeping deficiencies, including repeat observations of biofilm and mold on sprout growing drums and a failure to sanitize equipment. The firm also lacked proper documentation for seed treatments and cleaning activities, and did not implement an environmental monitoring plan for Listeria monocytogenes. These issues indicate significant non-compliance with food safety regulations.